Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review
Authors
Keywords
-
Journal
Antioxidants
Volume 10, Issue 1, Pages 103
Publisher
MDPI AG
Online
2021-01-13
DOI
10.3390/antiox10010103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melatonin modulates mitophagy, innate immunity and circadian clocks in a model of viral‐induced fulminant hepatic failure
- (2020) Irene Crespo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
- (2020) Gang Wang et al. Cell Death & Disease
- Melatonin Regulates Cisplatin Resistance and Glucose Metabolism Through Hippo Signaling in Hepatocellular Carcinoma Cells
- (2020) Lina Mi et al. Cancer Management and Research
- Sirt3 promotes hepatocellular carcinoma cells sensitivity to regorafenib through the acceleration of mitochondrial dysfunction
- (2020) Ruobing Wang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Transcriptomic analysis on the effects of melatonin in gastrointestinal carcinomas
- (2020) Lu Ao et al. BMC GASTROENTEROLOGY
- Switching Diseased Cells from Cytosolic Aerobic Glycolysis to Mitochondrial Oxidative Phosphorylation: A Metabolic Rhythm Regulated by Melatonin?
- (2020) Russel J. Reiter et al. JOURNAL OF PINEAL RESEARCH
- Role of the Angiogenic Factors in Cholangiocarcinoma
- (2019) Romina Mancinelli et al. Applied Sciences-Basel
- Melatonin maximizes the therapeutic potential of non-preconditioned MSCs in a DEN-induced rat model of HCC
- (2019) Mohammed A. El-Magd et al. BIOMEDICINE & PHARMACOTHERAPY
- Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
- (2019) Lingyun Zhang et al. Cells
- Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
- (2019) Flavia Fondevila et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
- (2019) Cristian Scheau et al. Analytical Cellular Pathology
- Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review
- (2019) Paula Fernández-Palanca et al. Nutrients
- Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells
- (2019) Carolina Méndez-Blanco et al. Cancers
- Melatonin differentially modulates NF-КB expression in breast and liver cancer cells
- (2018) Jucimara F Colombo et al. Anti-Cancer Agents in Medicinal Chemistry
- Effect of Daytime Blue-enriched LED Light on the Nighttime Circadian Melatonin Inhibition of Hepatoma 7288CTC Warburg Effect and Progression
- (2018) Robert T Dauchy et al. COMPARATIVE MEDICINE
- Apoptosis: A Target for Anticancer Therapy
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melatonin modulates dysregulated circadian clocks in mice with diethylnitrosamine-induced hepatocellular carcinoma
- (2018) Diana I. Sánchez et al. JOURNAL OF PINEAL RESEARCH
- Melatonin suppresses eosinophils and Th17 cells in hamsters treated with a combination of human liver fluke infection and a chemical carcinogen
- (2018) Wachanan Wongsena et al. Pharmacological Reports
- Molecular bases of the poor response of liver cancer to chemotherapy
- (2018) Jose J.G. Marin et al. Clinics and Research in Hepatology and Gastroenterology
- Melatonin Attenuates Dysregulation of the Circadian Clock Pathway in Mice With CCl4-Induced Fibrosis and Human Hepatic Stellate Cells
- (2018) Bárbara González-Fernández et al. Frontiers in Pharmacology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Melatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction
- (2018) Tong-Hong Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair
- (2018) Chin-Chuan Chen et al. Cancers
- The Role of Angiogenesis in Hepatocellular Carcinoma
- (2018) Michael A. Morse et al. CLINICAL CANCER RESEARCH
- Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
- (2017) Liang Cheng et al. International Journal of Biological Sciences
- Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
- (2017) Russel Reiter et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma
- (2017) Shibo Lin et al. JOURNAL OF PINEAL RESEARCH
- Melatonin, a novel selective ATF-6 inhibitor, induces human hepatoma cell apoptosis through COX-2 downregulation
- (2017) Li-Jia Bu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation
- (2017) Tong-Hong Wang et al. Oncotarget
- Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy
- (2017) Néstor Prieto-Domínguez et al. Oncotarget
- Melatonin for the prevention and treatment of cancer
- (2017) Ya Li et al. Oncotarget
- Melatonin enhances the anti-tumor effect of sorafenib via AKT/p27-mediated cell cycle arrest in hepatocarcinoma cell lines
- (2017) Fei Long et al. RSC Advances
- Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma
- (2016) Diana I. Sánchez et al. JOURNAL OF PINEAL RESEARCH
- Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy
- (2016) Néstor Prieto-Domínguez et al. JOURNAL OF PINEAL RESEARCH
- Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells
- (2016) JUCIMARA COLOMBO et al. Oncology Letters
- Modulation of Autophagy by Sorafenib: Effects on Treatment Response
- (2016) Nestor Prieto-Domínguez et al. Frontiers in Pharmacology
- Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells
- (2015) Raquel Ordoñez et al. JOURNAL OF PINEAL RESEARCH
- Melatonin induces apoptosis in cholangiocarcinoma cell lines by activating the reactive oxygen species-mediated mitochondrial pathway
- (2015) UMAWADEE LAOTHONG et al. ONCOLOGY REPORTS
- Effect of melatonin on antioxidant status and circadian activity rhythm during hepatocarcinogenesis in mice
- (2015) Perumal Subramanian et al. Journal of Cancer Research and Therapeutics
- Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis
- (2015) Andrea Janz Moreira et al. PLoS One
- Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells
- (2013) S Carbajo-Pescador et al. BRITISH JOURNAL OF CANCER
- Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review
- (2013) Mariano Bizzarri et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Melatonin inhibits cholangiocarcinoma and reduces liver injury inOpisthorchis viverrini-infected andN-nitrosodimethylamine-treated hamsters
- (2013) Umawadee Laothong et al. JOURNAL OF PINEAL RESEARCH
- Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting Survivin and XIAP
- (2013) Lulu Fan et al. JOURNAL OF PINEAL RESEARCH
- Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells
- (2013) Raquel Ordoñez et al. JOURNAL OF PINEAL RESEARCH
- Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing Survivin
- (2013) Lulu Fan et al. JOURNAL OF PINEAL RESEARCH
- Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells
- (2012) S Carbajo-Pescador et al. BRITISH JOURNAL OF CANCER
- Antagonistic Effects of a 50 Hz Magnetic Field and Melatonin in the Proliferation and Differentiation of Hepatocarcinoma Cells
- (2012) María Antonia Cid et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Melatonin, A Natural Programmed Cell Death Inducer in Cancer
- (2012) M. Sánchez-Hidalgo et al. CURRENT MEDICINAL CHEMISTRY
- Involvement of melatonin in autophagy-mediated mouse hepatoma H22 cell survival
- (2012) Chang Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A review of the molecular aspects of melatonin’s anti-inflammatory actions: recent insights and new perspectives
- (2012) José L. Mauriz et al. JOURNAL OF PINEAL RESEARCH
- Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth
- (2011) Yuyan Han et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor
- (2011) Sara Carbajo-Pescador et al. JOURNAL OF PINEAL RESEARCH
- Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis
- (2011) Lixia Zha et al. JOURNAL OF PINEAL RESEARCH
- Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines
- (2010) Zu-Yau Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Protective effect of melatonin against Opisthorchis viverrini-induced oxidative and nitrosative DNA damage and liver injury in hamsters
- (2010) Umawadee Laothong et al. JOURNAL OF PINEAL RESEARCH
- Melatonin and Doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines
- (2010) Lu-Lu Fan WORLD JOURNAL OF GASTROENTEROLOGY
- Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells
- (2009) Sara Carbajo-Pescador et al. JOURNAL OF PINEAL RESEARCH
- Circadian disruption accelerates liver carcinogenesis in mice
- (2009) Elisabeth Filipski et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Antiangiogenic Drugs: Current Knowledge and New Approaches to Cancer Therapy
- (2008) Jose L. Mauriz et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line
- (2008) Javier Martín-Renedo et al. JOURNAL OF PINEAL RESEARCH
- 24-Hour rhythms in oxidative stress during hepatocarcinogenesis in rats: effect of melatonin or α-ketoglutarate
- (2008) Perumal Subramanian et al. REDOX REPORT
- Resveratrol inhibits tumor necrosis factor-α-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells
- (2007) Haibo Yu et al. BIOMEDICINE & PHARMACOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started